Hepatitis Newswire (Page 2)

Comprehensive Real-Time News Feed for Hepatitis. (Page 2)

Results 21 - 40 of 8,271 in Hepatitis

  1. LFR Discussing Ebola Response OptionsRead the original story

    Thursday | KFOR-AM Lincoln

    ... onin told KFOR News LFR personnel are trained to deal with a variety of communicable diseases, ranging from Flu to Hepatitis, but added Ebola is much more serious because it's so contagious, and because so much is unknown about it.

    Comment?

  2. Alnylam to Webcast Presentation at the Nomura Biotechnology ConferenceRead the original story

    Thursday | Business Wire

    ... (AAT) for the treatment of AAT deficiency-associated liver disease; ALN-HBV, an RNAi therapeutic targeting the hepatitis B virus (HBV) genome for the treatment of HBV infection; ALN-TMP, an RNAi therapeutic targeting TMPRSS6 for the treatment of ...

    Comment?

  3. Is Gilead Sciences a Worthy Investment?Read the original story

    Thursday | GuruFocus.com

    ... high. Investors have been counting on Gilead's promise of a booming, multi-billion-dollar market for drugs to cure Hepatitis C. But, the bigger question is how long will this excitement last, since the cost of this medicine is extremely high. Gilead ...

    Comment?

  4. Hepatitis A in a Food Service WorkerRead the original story

    Thursday | State of Maine

    Maine Center for Disease Control and Prevention identified a case of acute hepatitis A virus infection in a Cumberland County food service worker. The case served food while infectious from September 29, 2014 thru October 11, 2014.

    Comment?

  5. Global Infection Outbreaks, Unique Diseases Rising Since 1980Read the original story w/Photo

    Jul 12, 2010 | Science Daily

    ... shaded nations had more outbreaks. Enterovirus. Tuberculosis. Cholera. Measles. Various strains of the flu and hepatitis. The number of infectious disease outbreaks and the number of unique illnesses causing them appear to be increasing around the ...

    Comment?

  6. Education and awareness needed to combat 'global epidemic' of liver diseaseRead the original story

    Thursday | PressReleasePoint

    ... or at least easily treatable, since more than 90% of liver disease can be put down to alcohol, infection with hepatitis viruses (B and C), or obesity-related disease. The liver damage caused by any of these three agents can lead to fibrosis and ...

    Comment?

  7. Were Gilead's Earnings Really A Disappointment?Read the original story w/Photo

    Thursday | Seeking Alpha

    ... treatment of HIV) and Viread (which accounts for 4.62% of total sales and is used for the treatment of HIV-1 and hepatitis B), and a triple digit increase in Stribild (which accounts for 5.5% of total sales and is used for the treatment of HIV/AIDS) ...

    Comment?

  8. National Cancer Institute supports next-generation Austrian HPV vaccineRead the original story w/Photo

    Thursday | PhysOrg Weblog

    ... just one antigen (HPV16 RG1-VLP) and is therefore technically easier and more economical to manufacture. After the hepatitis B vaccine, the HPV vaccine is so far only the second effective cancer vaccine . Good Manufacturing Practice (GMP) means ...

    Comment?

  9. SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10thRead the original story

    Thursday | Freshnews

    ... lead product, ZADAXIN (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as a vaccine adjuvant, according to the local regulatory approvals. Through its ...

    Comment?

  10. Request A Test Offers 10% off STD Testing This NovemberRead the original story w/Photo

    Thursday | PRWeb

    ... Request A Test has a full selection of lab tests for common STD's like Chlamydia, Gonorrhea, Syphilis, Herpes and Hepatitis. They also offer a variety of tests for HIV . These tests are available individually or in several cost saving packages such ...

    Comment?

  11. Medivir and county councils conclude agreement on Olysio -based treatment for hepatitis CRead the original story

    Thursday | Business Wire

    Medivir AB announces that the company has entered into an agreement with Swedish county councils regarding the treatment of hepatitis C with OlysioA . The Dental and Pharmaceutical Benefits Agency has concluded that treatment with OlysioA is beneficial from a health economics viewpoint in the treatment of HCV genotypes 1 and 4 with METAVIR scores of F3-F4, irrespective of previous treatment.

    Comment?

  12. New databse shows global increases in infection outbreaks, unique diseases rising since 1980Read the original story

    Thursday | Medical News Today

    Enterovirus. Tuberculosis . Cholera . Measles . Various strains of the flu and hepatitis .

    Comment?

  13. The past 10 years of gastroenterology and hepatology-reflections and predictionsRead the original story

    Tuesday Oct 7 | Nature Reviews Gastroenterology and Hepatology

    ... and hepatology research in the past 10 years? Scott L. Friedman. Without question, the stunning advances in hepatitis C therapies represent the most important advance in hepatology in the past decade. Discovery of the causative agent in 1989 led to ...

    Comment?

  14. Medivir and county councils conclude agreement on OlysioA -based treatment for hepatitis CRead the original story

    Thursday | Business Wire

    Medivir AB announces that the company has entered into an agreement with Swedish county councils regarding the treatment of hepatitis C with OlysioA . The Dental and Pharmaceutical Benefits Agency has concluded that treatment with OlysioA is beneficial from a health economics viewpoint in the treatment of HCV genotypes 1 and 4 with METAVIR scores of F3-F4, irrespective of previous treatment.

    Comment?

  15. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model.Read the original story

    Wednesday | CiteULike

    ... the model was examined. External validation was conducted using patients with cirrhosis who were enrolled in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) study. HCC developed in 1960 patients (5.6%) during a median ...

    Comment?

  16. Progressive fibrosis significantly correlates with hepatocellular...Read the original story

    Wednesday | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Hepatocellular carcinoma develops even in some patients who achieve a sustained virological response following treatment for hepatitis C virus infection.

    Comment?

  17. Nursing home delays to extend until the New YearRead the original story w/Photo

    Wednesday | Independent.ie

    ... Meanwhile, the minister said the Department of Health will continue to provide support for women infected with hepatitis C after receiving contaminated batches of the blood product Anti-D. But Positive Action - the support organisation criticised in ...

    Comment?

  18. Ebola Treatment Pathways in the United StatesRead the original story

    Wednesday | Scoop

    ... countermeasure against pandemic threats, including ebola and chronic viral pathogens such as HIV and Hepatitis C (HCV). To date, HemopurifierA therapy has been successfully administered in approximately one hundred treatment experiences in health ...

    Comment?

  19. EDITORIAL: The Obamacare virusRead the original story

    Wednesday | Washington Times

    ... that it had sold $2.8 billion worth of the drug called Sovaldi in the past quarter. This $84,000 drug cures Hepatitis C, a liver ailment responsible for about 15,000 deaths annually. It has one major side effect: It infects politicians with ...

    Comment?

  20. Alnylam to Webcast Conference Call Discussing Third Quarter 2014 Financial ResultsRead the original story

    Wednesday Oct 29 | Information Technology

    ... (AAT) for the treatment of AAT deficiency-associated liver disease; ALN-HBV, an RNAi therapeutic targeting the hepatitis B virus (HBV) genome for the treatment of HBV infection; ALN-TMP, an RNAi therapeutic targeting TMPRSS6 for the treatment of ...

    Comment?